{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:16:40Z","timestamp":1788985000360,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hfc.2026.07.007","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:16:12Z","timestamp":1785874572000},"page":"463-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amyloidosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Valentina","family":"Allegro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Indennidate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lalario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldostefano","family":"Porcari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2026.07.007_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.hfc.2024.02.001","article-title":"Amyloidosis and amyloidogenesis: one name, many diseases","volume":"20","author":"Pozzan","year":"2024","journal-title":"Heart Fail Clin"},{"issue":"10","key":"10.1016\/j.hfc.2026.07.007_bib2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1161\/CIRCRESAHA.121.318187","article-title":"Pathophysiology and therapeutic approaches to cardiac amyloidosis","volume":"128","author":"Griffin","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2026.07.007_bib3","article-title":"Transthyretin cardiac amyloidosis","volume":"118","author":"Porcari","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hfc.2026.07.007_bib4","article-title":"AL amyloidosis for cardiologists: awareness, diagnosis, and future prospects: JACC: cardiooncology state-of-the-art review","volume":"4","author":"Wechalekar","year":"2022","journal-title":"JACC (J Am Coll Cardiol): Cardio-Oncology"},{"key":"10.1016\/j.hfc.2026.07.007_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.hfc.2026.07.007_bib6","unstructured":"Papingiotis G, Basmpana L, Farmakis D. Cardiac amyloidosis: epidemiology, diagnosis and therapy . e-Journal of Cardiology Practice - European Society of Cardiology (ESC). 2021. Available at: https:\/\/www.escardio.org\/communities\/councils\/cardiology-practice\/scientific-documents-and-publications\/ejournal\/volume-19\/cardiac-amyloidosis-epidemiology-diagnosis-and-therapy\/."},{"key":"10.1016\/j.hfc.2026.07.007_bib7","doi-asserted-by":"crossref","first-page":"1026440","DOI":"10.3389\/fcvm.2022.1026440","article-title":"Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies","volume":"9","author":"Porcari","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.hfc.2026.07.007_bib8","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3390\/biomedicines10071566","article-title":"Re-definition of the epidemiology of cardiac amyloidosis","volume":"10","author":"Rossi","year":"2022","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.hfc.2026.07.007_bib9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-Chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2026.07.007_bib10","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1002\/ehf2.13360","article-title":"Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy","volume":"8","author":"Devesa","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"4","key":"10.1016\/j.hfc.2026.07.007_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.hfc.2026.07.007_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ejhf.2824","article-title":"Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis","volume":"25","author":"Aimo","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2026.07.007_bib13","first-page":"122","article-title":"ECG\/echo indexes in the diagnostic approach to amyloid cardiomyopathy: a head-to-head comparison from the AC-TIVE study","author":"Pagura","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hfc.2026.07.007_bib14","doi-asserted-by":"crossref","DOI":"10.2459\/JCM.0000000000001337","article-title":"Red flags for the diagnosis of cardiac amyloidosis: simple suggestions to raise suspicion and achieve earlier diagnosis","volume":"23","author":"Argiro\u2019","year":"2022","journal-title":"J Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.hfc.2026.07.007_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamacardio.2024.2555","article-title":"Redefining cardiac involvement and targets of treatment in systemic immunoglobulin AL amyloidosis","volume":"9","author":"Porcari","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2026.07.007_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hfc.2026.07.007_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.hfc.2026.07.007_bib18","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.3390\/jcm14134785","article-title":"Transthyretin amyloid Cardiomyopathy-2025 update: current diagnostic approaches and emerging therapeutic options","volume":"14","author":"Tsch\u00f6pe","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.hfc.2026.07.007_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2025.04.008","article-title":"Vutrisiran improves survival and reduces cardiovascular events in ATTR amyloid cardiomyopathy: HELIOS-B","author":"Witteles","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2026.07.007_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.hfc.2026.07.007_bib21","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","article-title":"Aortic stenosis and cardiac amyloidosis: JACC review topic of the week","volume":"74","author":"Ternacle","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2026.07.007_bib22","first-page":"1","article-title":"Cardiac amyloidosis and aortic stenosis: a state-of-the-art review","volume":"3","author":"Jaiswal","year":"2023","journal-title":"Eur Hear J Open [Internet]"},{"key":"10.1016\/j.hfc.2026.07.007_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/suac012.281","article-title":"Redefining the epidemiology of cardiac amyloidosis . A systematic review and meta-analysis of screening studies","author":"Aimo","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.hfc.2026.07.007_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcmg.2015.04.012","article-title":"Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis","volume":"9","author":"Longhi","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.hfc.2026.07.007_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCIMAGING.116.005066","article-title":"Occult transthyretin cardiac amyloid in severe calcific aortic stenosis","volume":"9","author":"Treibel","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.hfc.2026.07.007_bib26","first-page":"42","article-title":"Stenosi aortica \u201cparadoxical low flow-low gradient\u201d: Luci ed ombre","volume":"25","author":"Polizzi","year":"2024","journal-title":"G Ital Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2026.07.007_bib27","first-page":"524","article-title":"2021 ESC\/EACTS guidelines for the managementof valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"75","author":"Vahanian","year":"2022","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.hfc.2026.07.007_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.amjcard.2023.04.003","article-title":"Transcatheter aortic valve implantation in cardiac amyloidosis and aortic stenosis","volume":"198","author":"Riley","year":"2023","journal-title":"Am J Cardiol [Internet]"},{"key":"10.1016\/j.hfc.2026.07.007_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.amjcard.2022.06.026","article-title":"Temporal trends and outcomes of transcatheter and surgical aortic ValveReplacement in patients with cardiac amyloidosis and severe aortic stenosis","author":"Gupta","year":"2022","journal-title":"Am J Cardiol"},{"issue":"22","key":"10.1016\/j.hfc.2026.07.007_bib30","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2026.07.007_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.hfc.2024.03.005","article-title":"Specific therapy in transthyretin amyloid cardiomyopathy: future perspectives beyond tafamidis","volume":"20","author":"Saro","year":"2024","journal-title":"Heart Fail Clin"},{"issue":"2","key":"10.1016\/j.hfc.2026.07.007_bib32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/13506129.2020.1857236","article-title":"Beyond Val30Met transthyretin (TTR): variants associated with age-at-onset in hereditary ATTRv amyloidosis","volume":"28","author":"Alves-Ferreira","year":"2021","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.hfc.2026.07.007_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (transthyretin amyloid outcome survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2026.07.007_bib34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40120-021-00258-z","article-title":"Characteristics of patients with Late- vs. early-onset Val30Met transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey (THAOS)","volume":"10","author":"Waddington-Cruz","year":"2021","journal-title":"Neurol Ther"},{"issue":"3","key":"10.1016\/j.hfc.2026.07.007_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/13506129.2021.1917357","article-title":"Neurological involvement in Ile68Leu (p.Ile88Leu) ATTR amyloidosis: not only a cardiogenic mutation","volume":"28","author":"Pastorelli","year":"2021","journal-title":"Amyloid"},{"issue":"7","key":"10.1016\/j.hfc.2026.07.007_bib36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.neurol.2025.06.007","article-title":"Description of peripheral nervous system involvement in wild-type transthyretin amyloidosis: a clinical and electrophysiological study","volume":"181","author":"Barriol","year":"2025","journal-title":"Rev Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.hfc.2026.07.007_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10072-020-04889-2","article-title":"Hereditary transthyretin amyloidosis overview","volume":"43","author":"Manganelli","year":"2022","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.hfc.2026.07.007_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/ncn3.12601","article-title":"Amyloid neuropathy and autonomic dysfunction","volume":"10","author":"Ikeda","year":"2022","journal-title":"Neurol Clin Neurosci"},{"issue":"17","key":"10.1016\/j.hfc.2026.07.007_bib39","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release","volume":"72","author":"Sperry","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hfc.2026.07.007_bib40","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jhsa.2019.06.016","article-title":"Carpal tunnel syndrome: a potential early, red-flag sign of amyloidosis","volume":"44","author":"Donnelly","year":"2019","journal-title":"J Hand Surg Am"},{"issue":"1","key":"10.1016\/j.hfc.2026.07.007_bib41","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ehf2.13606","article-title":"Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery","volume":"9","author":"Porcari","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"10","key":"10.1016\/j.hfc.2026.07.007_bib42","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2022.06.026","article-title":"Screening for cardiac amyloidosis 5 to 15 years after surgery for bilateral carpal tunnel syndrome","volume":"80","author":"Westin","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2026.07.007_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12265-019-09895-0","article-title":"Prevalence of cardiac amyloidosis in patients with carpal tunnel syndrome","volume":"12","author":"Zegri-Reiriz","year":"2019","journal-title":"J Cardiovasc Transl Res"},{"issue":"8","key":"10.1016\/j.hfc.2026.07.007_bib44","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/17531934231218997","article-title":"Prevalence of transthyretin amyloidosis in patients undergoing carpal tunnel surgery: a prospective cohort study and risk factor analysis","volume":"49","author":"Brunet","year":"2024","journal-title":"J Hand Surg Eur Vol"},{"issue":"6","key":"10.1016\/j.hfc.2026.07.007_bib45","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","article-title":"Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy","volume":"268","author":"Adams","year":"2021","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.hfc.2026.07.007_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/13506129.2022.2043270","article-title":"Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"29","author":"Barroso","year":"2022","journal-title":"Amyloid"},{"issue":"13","key":"10.1016\/j.hfc.2026.07.007_bib47","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.3390\/jcm14134682","article-title":"Prevalence of autonomic dysfunction and correlation with markers of disease severity in cardiac amyloidosis","volume":"14","author":"Poledniczek","year":"2025","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.hfc.2026.07.007_bib48","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10741-021-10080-2","article-title":"Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness","volume":"27","author":"Nativi-Nicolau","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"10","key":"10.1016\/j.hfc.2026.07.007_bib49","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jamaneurol.2019.2917","article-title":"Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review","volume":"76","author":"Oaklander","year":"2019","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.hfc.2026.07.007_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/cjn.2021.34","article-title":"Canadian guidelines for hereditary transthyretin amyloidosis polyneuropathy management","volume":"49","author":"Alcantara","year":"2022","journal-title":"Can J Neurol Sci"},{"issue":"12","key":"10.1016\/j.hfc.2026.07.007_bib51","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/acn3.51924","article-title":"Amyloid detection and typing yield of skin biopsy in systemic amyloidosis and polyneuropathy","volume":"10","author":"Pinton","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.hfc.2026.07.007_bib52","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012965","article-title":"CNS involvement in hereditary transthyretin amyloidosis","volume":"97","author":"Sousa","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.hfc.2026.07.007_bib53","doi-asserted-by":"crossref","first-page":"1242815","DOI":"10.3389\/fneur.2023.1242815","article-title":"Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy","volume":"14","author":"Poli","year":"2023","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.hfc.2026.07.007_bib54","first-page":"189","article-title":"Current review of leptomeningeal amyloidosis associated with transthyretin mutations","volume":"26","author":"Qin","year":"2021","journal-title":"Neurol"},{"key":"10.1016\/j.hfc.2026.07.007_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13506120400000749","article-title":"MRI analysis on a patient with the V30M mutation is characteristic of leptomeningeal amyloid","volume":"11","author":"Mitsuhashi","year":"2004","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.hfc.2026.07.007_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13195-024-01407-w","article-title":"The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer\u2019s disease continuum participants","volume":"16","author":"Hong","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"10.1016\/j.hfc.2026.07.007_bib57","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR amyloidosis: current and emerging management strategies: JACC: cardiooncology state-of-the-art review","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10.1016\/j.hfc.2026.07.007_bib58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/13506129.2020.1798922","article-title":"Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation","volume":"28","author":"Cappelli","year":"2021","journal-title":"Amyloid"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713626000504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713626000504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:54:11Z","timestamp":1788983651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713626000504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1551713626000504"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2026.07.007","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2026.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}